arrow
W

William R. Miller

Houston Methodist Hospital
H指数:76
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa

铜绿假单胞菌全球队列中与cefiderocol敏感性降低及β-内酰胺/β-内酰胺酶抑制剂交叉耐药相关的基因组学特征和临床特征

2026-05-150
OA
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)

难治性肠球菌菌血症的临床与基因组学特征:一项多中心前瞻性队列研究(VENOUS)

2025-07-011
PRE
Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America
2025-03-010
PRE
Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection
2024-11-061
PRE
Membrane Lipids Augment Cell Envelope Stress Signaling via the MadRS System to Defend Against Antimicrobial Peptides and Antibiotics in Enterococcus faecalis

膜脂通过MadRS系统增强细胞包膜应激信号,以防御粪肠球菌中的抗菌肽和抗生素

2024-04-052
OA
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
2024-03-062
OA
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
2024-02-092
PRE
High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated ß-lactamase CMY-185 variant

新型质粒介导的 β-内酰胺酶CMY-185变体在大肠杆菌中产生高水平的头孢他啶/阿维巴坦耐药性

2023-08-1411
PRE
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA
2023-01-022
OAAI
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
2022-11-1511
OAAI